Register or Sign in to Save this opportunity, or Send an Inquiry.
Method for Identification of Allosteric Drug Binding Sites
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
Proprietary computer-based techniques that open up drug design for more selective modulation of proteins of interest
Send an Inquiry
RE:
Participants
You

Background


Conventional methods for protein-targeted drug design are very heavily biased towards exploiting those sites on the protein targets where other molecules are already known to bind. In the case of enzymes, this usually means seeking ligands that are capable of binding tightly to the catalytic sites in place of the substrate. The discovery of such

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Contact is welcomed from organisations interested in developing, licensing or exploiting this technology

FEATURED
Last Updated Feb 2014
Technology Type
Phase of Development EARLY STAGE
UNIVERSITY

Opportunity Contact